| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 芫花酚B; Genkwanol B | CFN91961 | 142674-67-7 | C30H22O11 = 558.49 | 5mg | QQ客服：3257982914 |
| 瑞香酚; Stelleranol | CFN91960 | 795308-62-2 | C30H22O11 = 558.49 | 5mg | QQ客服：2056216494 |
| 新柳杉双黄酮; Neocryptomerin | CFN91949 | 20931-36-6 | C31H20O10 = 552.48 | 5mg | QQ客服：1457312923 |
| 鸡毛松双黄酮A; Imbricataflavone A | CFN91946 | 133336-96-6 | C33H24O10 = 580.54 | 5mg | QQ客服：3257982914 |
| 圣草酚-6-葡萄糖苷; Eriodictyol-6-glucoside | CFN91945 | 118040-45-2 | C21H22O11 = 450.39 | 5mg | QQ客服：3257982914 |
| (R)-圣草酚-8-C-beta-D-葡萄糖苷; (R)-Eriodictyol-8-C-beta-D-glucopyranoside | CFN91943 | 1023271-51-3 | C21H22O11 = 450.39 | 5mg | QQ客服：215959384 |
| 圣草酚-8-葡萄糖苷; Eriodictyol-8-glucoside | CFN91942 | 153733-96-1 | C21H22O11 = 450.39 | 5mg | QQ客服：1457312923 |
| 5'-甲氧基川陈皮素; 5'-Methoxynobiletin | CFN91940 | 6965-36-2 | C22H24O9 = 432.42 | 5mg | QQ客服：215959384 |
| Mesopsin; Mesopsin | CFN91922 | 5989-16-2 | C15H12O6 = 288.25 | 5mg | QQ客服：1457312923 |
| Cudraflavone B; Cudraflavone B | CFN91905 | 19275-49-1 | C25H24O6 = 420.45 | 5mg | QQ客服：2159513211 |
| Shuterin; Shuterin | CFN91904 | 105377-77-3 | C20H20O6 = 356.37 | 5mg | QQ客服：215959384 |
| Montixanthone; Montixanthone | CFN91903 | 876305-36-1 | C14H10O6 = 274.23 | 5mg | QQ客服：2056216494 |
| Gericudranin E; Gericudranin E | CFN91902 | 172104-07-3 | C22H18O7 = 394.37 | 5mg | QQ客服：215959384 |
| 桂木生黄素; Artocarpesin | CFN91901 | 3162-09-2 | C20H18O6 = 354.35 | 5mg | QQ客服：215959384 |
| Hyperxanthone E; Hyperxanthone E | CFN91900 | 819860-76-9 | C18H16O6 = 328.32 | 5mg | QQ客服：1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)